BioLineRX Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BioLineRX Ltd. with three other
pharmaceutical manufacturers in Middle East:
Glaxo Smith Kline
sales of 726.84 million Egyptian Pounds [US$40.27 million]
of which 100%
was Pharmaceutical Products),
Memphis Pharmaceutical & Chemical Industries
(620.11 million Egyptian Pounds [US$34.35 million]
National Pharmaceutical Industries Co.
based in Oman
(5.74 million Omani Rials [US$14.90 million]